Abstract
Homeostasis across diverse ecosystems, ranging from human hosts to environmental matrices, is profoundly governed by microbial communities. Dysbiosis, the disruption of this microbial equilibrium, leads to significant adverse outcomes in medicine, agriculture, aquaculture, and environmental health. This review synthesizes current knowledge on microbial transfusions, defined as the deliberate transfer of microbial communities or their components to restore, reconstitute, or enhance functional capacities across these systems. We explore the historical context and cutting-edge applications, including Fecal Microbiota Transplantation (FMT) for Clostridioides difficile infection, metabolic and neurological disorders, alongside advancements in vaginal microbiota transplantation. In agriculture, we summarize the engineering of soil microbiomes for enhanced plant health, stress adaptation, and bioremediation, as well as transplantation practices in livestock and wild species. Furthermore, we discuss the role of microbiota transplantation in aquaculture for improving fish health and disease resistance, highlighting both natural and synthetic consortia. The application of microbial communities in bioremediation and ecological restoration is explored, addressing challenges such as stability, cost, and ecological impacts. Ultimately, this review integrates these diverse applications within a “One Health” framework, emphasizing the systemic links among human, animal, and environmental microbiomes. We underscore the potential of microbiota transplantation as a sustainable strategy for restoring ecological balance while identifying critical research gaps and future directions regarding standardized methodologies and the long-term functionality of transplanted microbiomes.
1 Introduction
Homeostasis, the fundamental dynamic equilibrium within biological systems, is critically mediated by microbial communities across all scales, from individual organisms to entire ecosystems (Manzanera, 2025). The intricate interplay between macro- and microorganisms, as exemplified by the gut microbiota of humans and animals (Wang X. et al., 2025), the plant rhizosphere (Hnini et al., 2025), and aquatic microbial communities (Thukral et al., 2023), is essential for maintaining stability and function.
However, detrimental factors such as antibiotic exposure, environmental stressors, and anthropogenic pollution can disrupt this delicate balance, leading to dysbiosis (Diambra, 2025). The consequences of dysbiosis are far-reaching, manifesting as disease in humans and animals, crop loss, and ecological degradation in soils and aquatic environments (Figure 1).
Figure 1
The restoration of microbial balance in dysbiotic ecosystems has emerged as a highly relevant and promising research area. While targeted microbial interventions have gained traction within specific disciplines, such as fecal microbiota transplantation in medicine, a comprehensive, cross-domain synthesis is critically needed to identify overarching principles, transferable technologies, and shared challenges that transcend disciplinary boundaries (Eren and Banfield, 2024; Kamble, 2024; Soth et al., 2025). Existing reviews have focused predominantly on single applications (e.g., FMT in medicine) or specific environmental contexts (restoration of disturbed soils; increasing plant yields by introducing PGPR (plant growth promoting rhizobacteria); wastewater recycling, and similar interventions). This has resulted in a significant gap in the literature regarding the pervasive nature and conceptual commonalities of microbial interventions across diverse ecosystems (Soth et al., 2025). This review explicitly addresses this gap by offering a holistic perspective on “microbial transfusions” as a unified conceptual framework, demonstrating how fundamental principles of microbial community restoration are universally applicable (Song, 2023).
We define “microbial transfusions” as the deliberate and targeted transfer of microbial communities—or their specific components—to reconstitute, restore, or enhance the functional capacity of a recipient microbiome. This definition emphasizes the therapeutic or ameliorative intent, focusing on the functional output and systemic impact of the transplanted microorganisms, rather than solely their source (e.g., fecal matter, soil, synthetic consortia) (Albright et al., 2021; Custer et al., 2023). This conceptual shift enables a unified discussion of diverse applications, fostering cross-disciplinary learning and innovation, and influencing research directions toward more harmonized and effective solutions.
The described approach to “microbiota transplantation” directly aligns with the principles of “One Health.” By focusing on the functional outcome of microbial transplantation, we recognize their role in the complex network of interactions between microbiomes in different environments. This allows us to move from targeted interventions to holistic strategies for preserving and improving microbiomes at all levels—from the organism to the ecosystem.
This review presents examples of microbial transfusions in human medicine, agriculture, aquaculture, and bioremediation, discusses their application in restoring environmental balance, examines associated risks, and explores the concept within the overarching “One Health” framework.
2 Microbial transplantation in medicine
The influence of the gut microbiota on the human body and overall wellbeing is a well-established fact (Kowal, 2025). A shift in the normal balance of “beneficial bacteria” toward an increase in opportunistic pathogens within the gut microbiota leads to adverse consequences, including diarrhea, constipation, irritable bowel syndrome, and other gastrointestinal diseases (Charitos et al., 2025; Shen, 2025), thereby reducing an individual's quality of life. Furthermore, recent studies have indicated that an imbalance in the gut microbiota may contribute to extra-intestinal diseases, including autism, cancer, and metabolic syndrome, among others. This presents a significant medical challenge, necessitating in-depth study and the development of therapeutic methods for maintaining a healthy balance of the gut microbiota (Biazzo and Deidda, 2022).
Fecal microbiota transplantation (FMT) from a healthy donor to a recipient with gut microbiota dysbiosis is an approach to treating intestinal dysbiotic conditions. The application of this method dates to ancient China (300–400 AD) and is currently experiencing a surge in popularity in research for treating various diseases associated with its imbalance. In certain countries, it is an effective therapy for Clostridioides difficile infection (CDI), caused by the opportunistic bacterium C. difficile (Wang et al., 2022) (Table 1).
Table 1
| Application area | Intervention type | Key research findings | Source |
|---|---|---|---|
| Recurrent CDI | Donor FMT via duodenal infusion | Therapeutic efficacy reached 94% after 1–2 infusions, significantly outperforming standard vancomycin therapy (500 mg orally, four times daily for 4 days). A concomitant increase in the Bacteroidetes and Clostridia and a decrease in Pseudomonadota were observed. | (Kelly et al., 2016; Van Nood et al., 2013) |
| Post-antibiotic gut microbiome restoration | Autologous FMT (auto-FMT) | The intervention demonstrated a more rapid and comprehensive reconstitution of the intestinal microbiome compared to commercial probiotic formulations. | (Suez et al., 2018) |
| Ulcerative colitis | Multi-donor FMT | Steroid-free clinical and endoscopic remission was achieved in 27% of patients in the FMT group vs. 8% in the placebo group. Microbial analysis linked higher diversity and specific taxa (e.g., genus Fusobacterium) to clinical outcomes. | (Paramsothy et al., 2017) |
| Metabolic syndrome | Lean-donor FMT | Improvement in insulin sensitivity was recorded at 6 weeks, alongside shifts in microbiota composition. However, these metabolic changes were not sustained at the 18-week follow-up. | (Kootte et al., 2017) |
| Obesity | Lean-donor FMT | In murine models, direct or horizontal transfer (co-housing) of “lean” microbiota prevented weight gain and the development of metabolic phenotypes in recipients harboring “obese” microbiota. | (Ridaura et al., 2013) |
| Hypertension management | FMT | Established a correlation between gut microbiota composition and blood pressure dynamics; specifically, a reduction in Eggerthella lenta and an increase in Prevotella copri levels were linked to blood pressure regulation. | (Fan et al., 2025; Lin et al., 2024; Zhong et al., 2021) |
| Microbiome recovery in oncology (allo-SCT) | Autologous FMT (auto-FMT) | Successfully restored gut microbiome composition and enhanced microbial diversity in patients following antibiotic therapy associated with allogeneic stem cell transplantation. | (Taur et al., 2018) |
| Parkinson's disease | FMT | Confirmed procedural safety and tolerability, with observed improvements in non-motor symptoms, including sleep quality and chronic constipation. | (DuPont et al., 2023; De Sciscio et al., 2025) |
| Recurrent bacterial vaginosis | Vaginal microbiota transplantation | Showed clinical improvement and successful restoration of a Lactobacillus-dominant vaginal microbiome in 4 out of 5 patients. | (Lev Sagie et al., 2019) |
Clinical applications and outcomes of FMT and VMT.
Analysis of the clinical trials presented in Table 1 highlights several key insights. First, there is a notable disparity in the efficacy of Fecal Microbiota Transplantation. Specifically, for treating recurrent Clostridioides difficile infection (CDI), efficacy rates ranged from 81% to 94%, significantly exceeding the results of standard vancomycin therapy as described in Van Nood et al. (2013) and Kelly et al. (2016). Conversely, when FMT was utilized for ulcerative colitis or metabolic syndrome, the effects were less pronounced, showing a 27% remission rate in ulcerative colitis (Paramsothy et al., 2017) and variable improvements in insulin sensitivity in metabolic syndrome (Kootte et al., 2017). This suggests a more complex, multifactorial etiology for these conditions.
Second, multiple studies, including those by Van Nood et al. (2013), Paramsothy et al. (2017), and Fan et al. (2025), have demonstrated that shifts in intestinal microbial diversity play a crucial role in improving clinical outcomes. These shifts often involve a reduction in the Pseudomonadota phylum and an increase in Bacteroidetes and Clostridia. These taxonomic changes are likely driven by the ability of Bacteroidetes and Clostridia to synthesize short-chain fatty acids such as butyrate and propionate, which exert anti-inflammatory effects (Porter and Larsbrink, 2022; Singh B. K. et al., 2023). These metabolites fulfill critical protective roles: butyrate serves as the primary energy source for colonocytes, strengthens epithelial tight junctions to restore barrier function, and suppresses inflammation by inhibiting NF-κB and promoting regulatory T-cell differentiation (Singh B. K. et al., 2023). Propionate, in turn, modulates systemic metabolic processes and suppresses inflammation via G-protein-coupled receptors (Porter and Larsbrink, 2022). Consequently, the reduction of the Pseudomonadota phylum, which contains many pathogenic and opportunistic taxa, is beneficial for both the gut and the overall organism (Young et al., 2026).
The high efficacy of FMT in recurrent CDI can be attributed to several synergistic mechanisms: FMT restores normal bile acid metabolism; donor bacteria, particularly those from the Bacteroides genus, express bile salt hydrolase enzymes that convert primary bile acids (which stimulate C. difficile spore germination) into secondary bile acids that do not (Lucky, 2025). Furthermore, the restoration of SCFA production, especially butyrate, not only reinforces the epithelial barrier but also directly disrupts C. difficile metabolic activity, inducing bacterial cell autolysis (Pilla et al., 2025). Finally, FMT modulates host innate immunity by inducing the expression of IL-22 and GM-CSF, promoting neutrophil activation and creating an environment hostile to C. difficile colonization (Khoruts et al., 2021).
Third, the findings of Suez et al. (2018) have shifted the paradigm of microbiome recovery, showing that commercial probiotics are less effective than autologous FMT (using the patient's own material collected before treatment) following antibiotic therapy. This challenges the universal use of probiotics and supports a personalized approach to microbiota restoration.
Fourth, the use of FMT to reconstruct the gut microbiome in oncology patients undergoing antibiotic therapy for allogeneic stem cell transplantation is critical (Taur et al., 2018), as these patients represent a high-risk group. Finally, preliminary research on FMT for treating hypertension and Parkinson's disease reveals, a clear link between the gut microbiota and these conditions, broadening our understanding of its systemic impact (Fan et al., 2025; De Sciscio et al., 2025).
In this context, clinical data on the use of Vaginal Microbiota Transplantation for recurrent bacterial vaginosis remain limited (Lev Sagie et al., 2019). However, its efficacy is increasingly discussed in literature reviews by Luo et al. (2024), Meng et al. (2024), and Tuniyazi and Zhang (2023). Furthermore, the existence of FDA-approved donor screening protocols and detailed methodologies for the collection and analysis of donor material establishes a solid foundation for its implementation in medical practice (Yockey et al., 2022).
Despite its positive aspects, FMT has several significant limitations, most notably the challenge of selecting healthy donors. A review of clinical data confirmed that the efficacy of FMT in chronic diseases (e.g., inflammatory bowel disease, type 2 diabetes) varies considerably depending on the donor. Some “super-donors” have clinical remission rates twice as high as those of other donors. This is attributed to the characteristics of their microbiota, including high diversity and the presence of “keystone species” such as butyrate-producing strains, which are critically important for immune and metabolic regulation (Wilson et al., 2019). The authors note that the “super-donor” phenomenon requires further research, including the standardization of selection criteria and long-term monitoring. For instance, the influence of viruses and fungi on FMT success remains unclear (Morales et al., 2024). Successful engraftment of donor strains after FMT primarily depends on the strain abundance in the donor and phylogenetic similarity to the recipient's microbiota. Smillie et al. (2018) demonstrated that strains of a single species colonize the recipient's gut according to an “all-or-nothing” principle.
Non-etheless, clinical data on FMT continue to accumulate, suggesting a promising trajectory toward its widespread implementation for the correction of human dysbiosis and the management of associated comorbidities in the foreseeable future. This perspective is reinforced by current comprehensive reviews addressing standardized procedural protocols. These include stringent donor selection criteria (e.g., rigorous screening for infectious agents and other pathologies), optimized material processing—notably the finding that freeze-thaw cycles do not compromise therapeutic efficacy—and diverse administration modalities, such as colonoscopy, nasogastric tubes, or oral capsules (Ooijevaar et al., 2019). Furthermore, critical discourse remains focused on safety profiles and potential risks (Cammarota et al., 2017; Bieganska et al., 2025), alongside the ethical and regulatory challenges associated with FMT commercialization and longitudinal safety (Allegretti et al., 2019; Ma et al., 2017; Daloiso et al., 2015). Additional considerations include the accessibility of the methodology (Cymbal et al., 2025) and the sustained impact of FMT on the recipient's gut microbiome architecture (Li et al., 2016). While these foundational studies primarily delineate the applications of fecal microbiota, we posit that the highlighted clinical, ethical, and technical frameworks are equally applicable to vaginal microbiota transplantation within the field of gynecology.
Microbial transfusions remain in early development, requiring long-term safety and efficacy studies. Synthetic microbial communities present a new direction, with synthetic biology advancing their design (Kumar et al., 2022; Nazir et al., 2024; Dou and Bennett, 2018). Yet clinical application depends on establishing causal host-microbiota links—complicated by interaction complexity. Further research using gnotobiotic models is therefore essential (Bolsega et al., 2021).
3 Microbial transplantation in agriculture
3.1 . Plants
Metagenome transplantation and the engineering of synthetic microbiomes have emerged as increasingly pivotal research frontiers, extending beyond human and veterinary medicine to encompass plant and edaphic ecosystems. This paradigm shift is intrinsically linked to the “One Health” framework, which recognizes the profound interdependence between the health of humans, animals, plants, and the surrounding environment, a topic which will be discussed in subsequent sections.
Substantial evidence in the current literature suggests that soil microbial communities can be strategically modified to manipulate plant traits and soil processes, thereby unlocking novel avenues for sustainable agricultural intensification. For instance, Panke-Buisse et al. (2015) investigated the influence of soil microbiomes on plant functional traits, specifically focusing on flowering phenology and productivity. Utilizing Arabidopsis thaliana and selected microbiomes, the authors identified specific taxa that either accelerate (e.g., Xanthomonadaceae, Pseudomonadaceae, Moraxellaceae, Cellulomonadaceae, and Saprospiraceae) or delay (e.g., Iamiaceae, Alcaligenaceae, Corynebacteriaceae, and Verrucomicrobiaceae) flowering. Their findings demonstrated that these microbiomes consistently modulated plant phenotypes across various A. thaliana genotypes and the related species Brassica rapa, with the notable exception of the Ler genotype. Furthermore, microbiomes associated with delayed flowering were linked to increased inflorescence biomass and enhanced activity of enzymes involved in soil nitrogen mineralization. Host-mediated microbiome selection represents a cornerstone of microbiome engineering, offering an innovative approach to augmenting both plant and animal health. Mueller and Sachs (2015) proposed utilizing host phenotypes as indicators to select microbial communities that confer beneficial traits, such as enhanced pathogen resistance or optimized nutrient acquisition. This methodology, rooted in artificial selection, quantitative genetics, and community ecology, facilitates the development of stable, functional microbiomes for clinical and agricultural applications. Such interventions are poised to bolster plant resilience to drought and disease, while simultaneously improving infection resistance in livestock (Ray et al., 2020). However, the authors also acknowledge significant challenges, including the complexity of predicting multi-species interactions and potential adverse ecological consequences. To optimize these methods, the implementation of the “Design-Build-Test-Learn” cycle—integrating metagenomics and synthetic biology—is recommended.
The intensive study of plant microbiome transformation and synthetic community development is driven by its critical role in mediating host adaptation to biotic and abiotic stressors. Consequently, this field has become a focal point in agricultural and ecological research. It is well-established that the composition and function of rhizosphere and phyllosphere microbial communities can determine plant resistance to pathogens, such as the Cotton Leaf Curl Virus, as well as tolerance to salinity and drought (Aqueel et al., 2023; de Bashan et al., 2012; Mendes et al., 2013).
The importance of microbiome engineering is further highlighted by its capacity to mitigate the impacts of salinity and water scarcity. Genera such as Pseudomonas and Bacillus have been shown to improve plant water status by synthesizing osmoprotectants and promoting root growth. Research on Arabidopsis underscores that soil microorganisms can enhance drought tolerance by modulating host hormonal signaling (Wubs et al., 2016). Furthermore, microbial communities in organic farming systems—characterized by an abundance of nitrogen-fixing and phosphorus-solubilizing bacteria—exhibit superior stress resilience compared to those in conventional systems (Hartmann et al., 2015).
Pérez Castro et al. (2019) observed that under drought conditions, microbial communities undergo metabolic shifts, transitioning from the decomposition of complex organic compounds to simpler substrates, which may ultimately diminish soil carbon use efficiency. A particularly salient aspect is the interaction between drought and invasive plant species; the latter further perturb microbial composition and activity, accelerating the decomposition of soil organic matter.
In conclusion, the development of synthetic microbiomes and the implementation of microbiome transplantation in crop science provide transformative opportunities for enhancing agricultural sustainability, overcoming climatic stressors, and pioneering innovative technologies for yield optimization.
3.2 . Animals
3.2.1 Polygastric
Since the 17th century, transfaunation (rumen fluid transfer) has been used to treat digestive disorders in cattle, such as rumen hypomotility and anorexia. This method restores the beneficial anaerobic microorganisms that normalize fermentation (Niederwerder, 2018; Chaitman et al., 2016).
Data are available summarizing the results of an experiment on calves supplemented with rumen fluid from donor cows. Results showed that the abundance of eight genera was significantly higher in the experimental group (namely, Acidiphilium, Jeotgalibaca, Polaribacter, Pseudodesulfovibrio, Bdellovibrio, Microbacterium, Eubacterium and Sporosarcina, belonging to four phyla: Firmicutes, Proteobacteria, Bacteroidetes, and Actinobacteria). Notably, the phyla Bacteroidetes, Firmicutes, and Proteobacteria were identified as the most abundant microbial phyla in the rumen of adult dairy cows. It is hypothesized that supplementation with rumen fluid may accelerate the development of a mature rumen microbial community in calves. Since the inoculum samples used for the experimental group were obtained from an adult cow, metatranscriptomic analysis provided the scientific community with compelling evidence for the successful transplantation of these adult cow-derived microbial phyla (Li et al., 2019).
Another study presented data suggesting that rumen fluid transfaunation in yaks significantly increased the alpha diversity of the fecal microbiota. Recipient animals showed increased abundance of bacteria such as Rikenellaceae_RC9_gut_group, Bacteroides, and Christensenellaceae_R-7_group. This was accompanied by an increased metabolism of terpenes and polyketones, amino acids, and energy (Zhang et al., 2025).
Discussion of the mechanisms occurring during transfaunation encompasses various aspects. For example, it is suggested that nutrients in rumen fluid from donor ruminants likely promote the growth of bacteria, protozoa, methanogens, and fungi, which is necessary for the restoration of normal microbiota (Jouany and Ushida, 1999). Inoculation with mature rumen fluid is known to consistently enrich recipients with key bacterial genera, including Eubacterium (Firmicutes), Acidiphilium (Proteobacteria), and Polaribacter (Bacteroidetes). This microbial shift results in a favorable change in fermentation patterns, specifically by increasing propionate concentrations and decreasing the acetate-to-propionate ratio (Arshad et al., 2021). Thus, transfaunation induces functional reprogramming at the community level—the introduction of exogenous microbiota disrupts existing niche equilibrium, initiating competitive exclusion, metabolic bypass, and complementary symbiosis, leading to optimized fermentation outcomes (Zhao et al., 2025).
DePeters and George (2014) found that transfaunation is effective for metabolic disorders in cows. Other researchers have confirmed its role in competitively excluding pathogens (Mandal et al., 2017).
A study by Rager et al. (2004) indicated that rumen microbiota transplantation (transfaunation) positively affected the health and productivity of cows after abomasal displacement surgery. Cows that underwent transfaunation exhibited better metabolic parameters, lower blood beta-hydroxybutyrate levels, and an optimal acetate-to-propionate ratio in the rumen. This reduced the need for additional intravenous dextrose therapy.
Another study revealed that rumen microbiota transfaunation in early-weaned Japanese Black calves altered the composition of the rumen microbial community and fermentation patterns. Although there were no significant differences in body weight or feed intake, transfaunation increased the proportions of acetate and butyrate while reducing propionic acid levels, thereby altering the ratio of short-chain fatty acids. Microbiota analysis showed increases in acetate- and butyrate-producing bacteria, Methanomassiliicoccaceae_group10, and Neocallimastix, and a decrease in Methanomicrobium (Takizawa et al., 2023).
Studies on the impact of transfaunation on microbiota composition and feeding efficiency in beef cattle suggest that introducing rumen fluid from adult animals changes the microbial community. This change increases the proportion of acetate- and butyrate-producing bacteria, which can improve energy metabolism. While no significant increase in productivity was observed, the shift in rumen fermentation suggests the potential of transfaunation to optimize digestion in beef breeds (Zhou et al., 2018). Increased diversity of the anaerobic bacterial community after transfaunation will promote the fermentation of complex carbohydrates (Sonnenburg and Bäckhed, 2016).
A study on small ruminants found that protozoal inoculation increased volatile fatty acid production, altered microbiota composition, and reduced methane emissions. However, the addition of total fauna resulted in more complex changes, including an increase in methanogens. The study highlights the key role of protozoa in regulating rumen metabolism and their potential for controlling methane emissions in ruminants. These data are important for developing strategies to reduce the environmental footprint of animal husbandry (Belanche et al., 2015). In contrast, another study investigating the long-term effects of defaunation (the removal of protozoa from the rumen) on digestion and methane production in ewes found no effect on dry matter digestibility or methane emissions, though it increased microbial protein flow and altered the volatile fatty acid profile (Bird et al., 2008).
3.2.2 Monogastric
When evaluating disease prevention in monogastric animals, one study found that transfaunation reduced the incidence of porcine circovirus-associated diseases in weaned piglets. This method is also used to stimulate immunity by transferring maternal antibodies through milk (Niederwerder et al., 2018). Another study demonstrated that fecal microbiota transplantation accelerates recovery from diarrhea in puppies with canine parvovirus infection and shortens hospitalization time (Pereira et al., 2018). However, it does not affect mortality rates (Chaitman et al., 2016). The procedure was safe and well tolerated, thereby making it a promising addition to standard therapy (Khanna et al., 2017). The microbial community has coevolved with host immunity and plays a crucial role in maintaining homeostasis (Kogut et al., 2020). The microbiota stimulates the development of immune cells, such as macrophages, dendritic cells, and IgA-producing B cells, which provide protection against pathogens, including Salmonella (Yoo et al., 2020). Conversely, the immune system regulates microbiota composition through mechanisms of innate and adaptive immunity, such as Toll-like receptor activation and cytokine production. Disruption of this balance can lead to dysbiosis, increasing susceptibility to infections and inflammatory diseases (Zheng et al., 2020). Rumen fluid transfer in horses is a promising yet understudied method. Despite the lack of rigorous clinical evidence, preliminary data and successful applications in other species suggest that it could be an option for treating refractory cases of dysbiosis (Mullen et al., 2018).
3.2.3 Wild and endangered species
Microbiota transplantation helps wild animals adapt to new habitats and food sources (Blyton and Whisson, 2019). Studies have found that a significant portion of the microbiome in leaf-eating insects is formed directly from food. Conversely, in large herbivores such as deer, the proportion of diet-dependent microorganisms is minimal (Zhu et al., 2021). Similarly, geographical location can influence the development of the gut microbiome in insectivorous bats (Dai et al., 2024). Animals of the same species living in the wild or in captivity have different bacterial community structures that provide energy to the body (Wang X. et al., 2025). One study revealed an adaptation mechanism by which the gut microbiota of Canadian cranes responds to changes in diet and environment (Xu et al., 2023). Cross-housing different animal species, both domestic (Zhang et al., 2022) and wild (Gao et al., 2025; Gogarten et al., 2018), promotes the formation of unique microbial communities through horizontal microbiota transplantation, increasing the homogeneity of these communities. The advantages of fecal microbiota transplantation in wild or captive animals include the control of infectious intestinal diseases and the ability to exploit new food resources after transplanting microbiota capable of digesting them. However, there are significant challenges in collecting feces for research, including the liquid or semi-liquid fecal consistency and as well as the practical challenges of collecting samples from healthy and diseased animals, especially for aquatic species. Taken together, these studies highlight the potential of fecal microbiota transplantation as a non-invasive strategy for improving the health, adaptability, and wellbeing of captive or endangered animals.
For example, in a study (Linnehan et al., 2024), fecal microbiota transplantation in bottlenose dolphins (Tursiops truncatus) under controlled conditions showed promise as a therapeutic tool for restoring gut microbiota without the use of antibiotics. In a dolphin exhibiting clinical symptoms during the study, 62 of the 205 introduced taxa (30%) showed engraftment in the experiment. The lowest percentage similarity between samples before and after FMT was also observed, indicating the greatest changes induced by fecal microbiota transplantation therapy. Prior to fecal microbiota transplantation, the dolphin's intestine was dominated by three bacterial species: Paeniclostridium sordellii (50.00% relative abundance), C. perfringens (20.37% relative abundance), and Photobacterium damselae (16.92% relative abundance), all of which are potential pathogens. Immediately after the first fecal microbiota transplant, an increase in the alpha diversity of the recipient's gut community and a sharp decrease in the relative abundance of these three species were observed. This coincided with significant clinical improvements in the dolphin's dysbiosis symptoms, such as improved appetite, decreased nausea, and reduced diarrhea.
An example of fecal microbiota transplantation can be found in cases of coprophagy in the wild. It is believed, for example, that consuming the feces of their chicks helps adult precocial birds stabilize their gut microbiota. This proposed mechanism may enhance microbial metabolism and help maintain energy balance in the host (Hu et al., 2022). However, it is important to note that this idea, while of considerable scientific interest, is currently purely speculative and requires substantial empirical confirmation. Existing data remains fragmentary and does not allow for definitive conclusions; further research is needed to verify the hypotheses. Fecal transplantation, achieved through coprophagy or oral administration of specific bacteria, is also being explored as a potential method for improving animal health in veterinary medicine and wildlife conservation (Bornbusch et al., 2021).
For example, it has been shown that consuming feces can help herbivores (e.g., ostriches) maintain the diversity and functionality of their gastrointestinal microbiome. The microbiomes of chickens administered fecal supplements differed not only in community composition but also in phylogenetic structure, and taxonomic abundance. 1 week after the start of the experiment, 318 differentially abundant amplicons were detected in chickens fed the fecal supplement compared to the control. Two-thirds of all these differentially abundant taxonomic units (65.8%) were more abundant in the groups supplemented with the fecal supplement compared to the controls, consistent with their higher alpha diversity. However, taxa typically associated with young age in ostriches (e.g., Akkermansia, Blautia, and Dorea) were significantly underrepresented in chickens fed the fecal supplement. For example, Akkermansia muciniphila was highly prevalent in control chicks at 1 week of age, while it was completely absent from chicks of the same age in the groups receiving a fecal supplement. Conversely, bacterial genera closely associated with adults, such as Oscillospira, Treponema, Methanobrevibacter, BF311, and YRC22, were more abundant in chicks receiving fecal supplements than in controls throughout the experiment (Videvall et al., 2023).
Thus, coprophagy in the wild leads to accelerated microbiota maturation, increased diversity, reduced pathogen burden, and enhanced growth and survival, indicating its importance for the development of young animals and the transmission of microorganisms. On the other hand, coprophagy may lead to the transmission of pathogens.
4 Microbial transplantation in aquaculture
The gut microbiome of fish significantly influences growth characteristics, metabolism, feeding behavior, disease resistance, and immune response (Yukgehnaish et al., 2020). When discussing the fish gut microbiota, it is important to note that its composition depends on many factors and is divided into two types: transient microbiota, which enters the body with food and does not remain for long, and resident microbiota, which permanently inhabits the body and has a stable connection with the gut (Diwan et al., 2022). The composition and quality of the habitat, geographical distribution, and species affiliation of a particular individual greatly affect the formation and functioning of the microbiota of marine and freshwater inhabitants. The results showed that habitat and host species are the primary determinants of the fish gut microbiome structure (Kanika et al., 2025).
One approach involves using probiotic strains isolated from healthy fish, or fecal microbiota transplantation from a donor to a recipient. These studies are being conducted worldwide and are gaining increasing momentum each year. For instance, Sequeiros et al. (2015). demonstrated that the Lactococcus lactis TW34 strain, isolated from marine fish microbiota, can produce the bacteriocin nisin Z, which inhibits the growth of the fish pathogen Lactococcus garvieae. This pathogen causes hemorrhagic septicemia in marine fish of the Far East, particularly in rainbow trout, Japanese amberjack, cobia, and gray mullet. Another study identified that a bacterial isolation from the gut microbiota of a deep-sea shark, presumably Bacillus amyloliquefaciens, can produce an antimicrobial peptide with antibacterial activity against bacterial pathogens, including Salmonella typhimurium, Proteus vulgaris, Clostridium perfringens, and Staphylococcus aureus, among others (Bindiya et al., 2015).
In this context, fecal microbiota transplantation from a donor to a recipient seems to be a more promising method for restoring fish gut microbiota, as this method utilizes not just one “beneficial microbe” but rather an entire consortium of microorganisms with stable relationships. It is important to note that this strategy involves two approaches:
Using naturally evolved microbiota from healthy donors to restore the dysbiotic state of recipients (El Son et al., 2025).
Using specially developed synthetic microbial communities with known beneficial properties (Guo et al., 2023; El Son et al., 2025).
The second approach may become preferable in the future, as synthetic microbial communities could include genetically modified strains with improved functions, but this requires further careful research for practical application (Tayyab et al., 2025).
Nevertheless, both approaches enable the correction of dysbiotic conditions in aquaculture, thereby improving product quality. For example, fecal microbiota transplantation from healthy koi carp has been shown to hasten the restoration of the intestinal microbiota of recipient fish after florfenicol therapy, eliminate intestinal dysfunction, and restore normal metabolite synthesis compared to natural recovery. FMT promoted the restoration of microbiota species richness and diversity by restoring populations of beneficial bacteria that were reduced by florfenicol, such as Romboutsia, Bacteroides, Streptococcus, Lactobacillus and Faecalibacterium (Han et al., 2024). Raymo et al. (2024) demonstrated that, despite weight-normalized diets, rainbow trout larvae receiving microbiome cocktails from individuals with high filet yield showed a significant increase in somatic mass as early as 27 weeks post-hatching. Two studies by Hu et al. (2022b) examined the use of FMT in zebrafish to mitigate the effects of perfluorobutanesulfonate (PFBS), a highly toxic substance that can affect the visual system, in the context of environmental pollution. The first study demonstrated the effectiveness of transplanting feces from young individuals into older individuals, alleviating metabolic disorders caused by aging and environmental pollution (Hu et al., 2022a). The second study continued the research on using FMT to restore fish health after PFBS exposure, emphasizing the effectiveness of FMT from young individuals in mitigating the effects of PFBS toxicity (Hu et al., 2022b). Chandravanshi et al. (2025) also confirmed the potential of microbiome transfusions to improve aquaculture health and survival.
However, along with the positive effects of FMT, there are some limitations and risks. These include the risk of horizontal gene transfer, host-specific microbiome variability (which complicates the development of generalized formulas), regulatory discrepancies across different jurisdictions, and socio-economic limitations restricting access in low- and middle-income countries (Tayyab et al., 2025). Additionally, the complexity of applying this approach involves technological challenges related to introducing donor microbiota to recipients. While researchers can precisely introduce donor microbiota via a probe in experimental settings, the method must be simple and economically viable on an industrial scale. This is often achieved by treating feed with an inoculum of the transplanted microbiota or by raising fish in an environment where the inoculum has been introduced. However, the effectiveness of this method is less effective than the more precise methods (Han et al., 2024; Raymo et al., 2024; Hu et al., 2022b).
Thus, FMT is currently a promising method for correcting dysbiotic conditions in aquaculture. However, its application requires a thorough analysis of the specific problem, careful selection of the donor microbiota, and the determination of the method by which the microbiota will be introduced to the recipient.
5 Microbial transplantation in soils
Today, humanity faces multiple challenges associated with climate change resulting from anthropogenic impact, and the accumulation of xenobiotics in the environment. Therefore, it is highly relevant to search for methods and technologies capable of restoring the natural state and ensuring the stable functioning of ecosystems. In this section, the role of microorganisms, which participate in many biogenic processes, is crucial (Han, 2020). This paper will further present an overview of existing results on the possibilities of using microorganisms for transplantation in bioremediation and environmental management.
The scientific community is currently paying attention to microbial transplantation technology for soil restoration. This microbial approach can be a turning point in restoring degraded lands (Wubs et al., 2016).
Its application has demonstrated significant potential for restoring degraded ecosystems and mitigating the effects of climate change by increasing microbial biodiversity and improving soil health (Sun et al., 2014; Benetkova et al., 2022).
Despite existing obstacles, the microbial transplantation method for soil restoration continues to develop. For example, Silva et al. (2023), along with other researchers, demonstrated that modified Bradyrhizobium strains increase soybean yield by 30%, improve soil health and increase yields under certain conditions. The effectiveness of these inoculants depends largely on soil type and environmental conditions, as these factors vary significantly by region. The potential of soil microbiomes to ensure agricultural sustainability by improving plant characteristics and mitigating stressors has recently been studied using the well-established approach of rhizosphere engineering. Soil microbiome transfer has also been successfully applied to protect plants (Morella et al., 2020; Anand et al., 2021; Zhang et al., 2021). Furthermore, soil microbiomes have found applications in other sectors, such as bioremediation and microbial fuel cells (Nitisoravut and Regmi, 2017). Thus, soil microbiomes can be considered as “next-generation biological preparations” with significant potential to ensure agricultural sustainability (Mitter et al., 2019).
As shown above, the potential of individual soil microbes and their consortia has traditionally been used in various biotechnological applications. However, to circumvent the main limitation of their application, limited survival and effectiveness in real systems, it became necessary to turn to microbiomes (Ray et al., 2020). Microbiomes are expected to be more stable and viable, with tightly regulated networks of interactions contributing to their effectiveness.
This approach is currently gaining widespread adoption. Although there are several reviews dedicated to soil microbiota in the context of restoration, most of them focus on the theoretical aspects of bacterial transplantation in soils (Coban et al., 2022; Contos et al., 2021; Rawat et al., 2022).
Ecosystem restoration involves mechanisms and species-specific responses that influence soil microbiota. These factors can contribute to achieving restoration goals and restoring the natural capacity of affected ecosystems for self-recovery. Various methods can be employed to influence soil microbiota and improve restoration outcomes:
1. Traditional methods (e.g., soil inoculation);
2. Non-traditional methods (e.g., using specific microbial cultures, improving seed quality).
One way to inoculate degraded ecosystems with soil microbiota and shift the microbial community toward one more characteristic of the target ecosystem is to transfer entire soil communities in the form of intact soil patches or homogenized soil. This essentially involves collecting soil from a reference ecosystem and transferring it directly to the restoration site (Koziol et al., 2018; Wubs et al., 2016). For example, Wubs et al. (2019) demonstrated that applying soil inoculants can have a long-term impact on the ecosystem, guiding and maintaining successional changes for at least two decades. However, Gerrits et al. (2023) reported that the direction of this effect depends on the suitability or compatibility of the translocated soil with the recipient site. Incompatibility can lead to disruption of microbial communities and changes in processes occurring in the soil.
Significant knowledge gaps persist regarding the effectiveness of soil translocation, including which methods are most effective (e.g., whole soil translocation, intact sod translocation, required volumes), the extent to which the physical and chemical properties of the soil at recipient sites influence establishment; how priority effects influence microbial community restoration (i.e., establishment may depend on the order of appearance of specific taxa); and how the merging of distinctly different soil communities affects successful establishment.
To overcome this limitation, a new approach has been proposed. It avoids widespread soil application and involves using local soil microbiota in the form of extruded granules or coatings as seed carriers (Gornish et al., 2019). This method can reduce the amount of soil needed by 100-fold (Stock et al., 2020). However, questions similar to those raised earlier regarding whole soil inoculation remain unresolved and are applicable here.
Increasing the availability and effectiveness of soil transplantation methods is linked to the successful implementation of natural microbiota acquisition methods. These methods can benefit key plant species used for restoration by improving seed quality (including seed extrusion and/or hydropriming with microbial additives) (Muñoz Rojas, 2018; Dadzie et al., 2022). Bioencapsulation, in which seeds are placed in protective polymers (natural and/or synthetic) that maintain inoculant viability, can also be used to enhance microbiota survival during storage and soil application (Brown et al., 2021). These methods are considered more suitable for large-scale field applications because they provide gradual and prolonged release of targeted microbiota. For example, they can be used in restoration sites to improve seed viability and introduce beneficial, selected microorganisms, such as cyanobacteria, to promote the formation of soil biocrusts (Román J et al., 2020).
Based on the aforementioned studies, it can be confidently stated that microbial communities are becoming useful tools for the bioremediation of contaminated environments. Despite their widespread use, these communities (consortia) are referred to by different terms, indicating a lack of consensus among specialists in this field (Massot et al., 2022). In studying this issue, we found that the origin of microbes and the degree of human intervention are usually considered when classifying microbiological consortia as natural (NMC), artificial (AMC), or synthetic (SMC). In this sense, NMCs are associations consisting of microorganisms derived from a single source, while members of AMCs originate from different sources. SMCs are a class of AMCs where the microbial composition is tailored for a specific task. However, researchers are questioning the existence of “gray areas” at the boundaries between each of the proposed categories of microbial consortia (Massot et al., 2022).
These initiatives have also highlighted the need to develop effective microbiome storage methods. Only a few studies have explored the concept of soil transplantation and its potential application to fresh soil microbiomes. While the application of soil microbiome transplantation is relatively new, the practice of fecal microbiome transplantation for improving human health has existed for quite some time (Kim and Gluck, 2019). Therefore, parallels can be drawn between the strategies used for fecal microbiome storage and the general strategy of preserving the microbiome in a matrix to maintain its functionality.
Soil microbiota can be manipulated to promote the restoration of degraded ecosystems by enhancing beneficial interactions between plant species and the soil microbiota, often lost in degraded environments (Aghili et al., 2014; Albornoz et al., 2022).
Based on scientific research and an analysis of existing literature, it can be concluded that microbial transplantation plays a significant role in soil restoration. Further study of this approach is required to increase its effectiveness in restoring ecological equilibrium.
Advances in DNA-based technologies and a deeper understanding of interactions between plants, soil, and ecosystems are enhancing our ability to use soil microbiota for restoration purposes (Mohr J et al., 2022). In this context, microbial transplantation represents a promising method for restoring contaminated ecosystems through the introduction of specialized microbial communities that degrade toxins, heavy metals, and organic pollutants.
The introduction of molecular genetic methods to study soil microbiome transplantation and the creation of synthetic microbial consortia has facilitated the investigation of various microbial taxa and their potential use for restoring specific ecosystem processes or relationships. For example, plant growth-promoting rhizobacteria can improve plant growth (Solans et al., 2022) and enhance germination (Domínguez Castillo et al., 2021). Chvojka (2025) presents one of the most promising new directions in creating fully synthetic microbial consortia. The study introduces Biorestorer—a systemic platform for initiating synthetic succession and synthetic pedogenesis in highly degraded or sterile substrates where natural restoration is impossible. The Biorestorer concept combines two-temperature biochar, rock-dissolving bacteria, and acidic minerals into a modular platform that reduces pH, retains water, and stimulates microbial colonization. This effectively initiates the soil formation process at an early stage. Rather than focusing on restoring natural vegetation or nutrients, Biorestorer views soil as a biotechnological interface, assembled and calibrated to operate in extreme environmental conditions. This approach is envisioned as a scalable tool for practical soil restoration, ecology, and land management in challenging environments. By combining ecological theory with engineered soil processes, this concept opens new possibilities for the accelerated restoration of soil functions and regenerative land management.
This comprehensive review has explored the multifaceted landscape of microbial transfusions, demonstrating their profound and expanding role in restoring and maintaining homeostasis across diverse biological and environmental systems. These interventions modulate human health and combat disease in medicine, enhance plant resilience and productivity in agriculture, bolster aquatic ecosystem health in aquaculture, remediate contaminated environments, and foster ecological restoration. Thus, microbial interventions represent a paradigm shift in addressing critical global challenges.
It should be noted that there are ongoing attempts to characterize the “healthy” and “unhealthy” microbiotas of plants, animals, and humans based on the Anna Karenina ecological principle (Arnault et al., 2023). In the case of soil, this principle can be described as follows: “All healthy microbiotas are alike; every unhealthy microbiota is unhealthy in its own way.” In experiments, the Anna Karenina principle often manifests in comparative analysis of various contaminations. After prolonged negative impact, experiments reveal the effect of PICT—specific resistance of soil microbiota to that impact. In various situations of soil contamination (surfactants, PAHs, petroleum products), this effect, according to researchers, also suggests a “treatment” strategy—ecological (not genetic) “editing” of the microbiome.
Based on the works summarized in this review, microbial inoculants offer significant opportunities for soil restoration and ecological farming, contributing to increased yields and plant growth (Chaudhary et al., 2022). Various artificially created bioinoculants with single or multiple microbial strains in their composition (consortium) can be used to ensure agricultural sustainability (Kumari et al., 2020; Kaur et al., 2022).
The fundamental premise underpinning these varied applications is the targeted manipulation of microbial communities to achieve desired functional outcomes (Albright et al., 2021; Custer et al., 2023). We have outlined the historical development of such practices, from ancient transfaunation techniques to cutting-edge synthetic microbial communities and underscored the transformative potential of next-generation sequencing and “omics” technologies in understanding their intricate mechanisms. The common threads of dysbiosis-driven problems and microbiome-based solutions are evident across all domains, emphasizing the interconnectedness of life on Earth.
Microbial transplantation hold promise but face challenges: standardizing donor selection, ensuring long-term stability of transferred communities, overcoming economic barriers, and addressing ethical concerns (Duhan et al., 2025; Nazir et al., 2024; Tayyab et al., 2025; Yadegar et al., 2024). Rigorous multidisciplinary research is needed to achieve mechanistic understanding amid the complexity of microbial ecosystems (Duhan et al., 2025; Lee et al., 2020).
Framed by the “One Health” concept (Lennon et al., 2023; Song, 2023), microbial transplantation represent holistic, sustainable tools rather than isolated therapies.
Future advancements require engineering synthetic consortia, using bioinformatics/AI for microbiome design, and implementing long-term monitoring. Interdisciplinary collaboration is essential to harness microbial transplantation for global health and sustainability.
6 Conclusion
The microbiomes of soil, plants, and animal guts play key roles in essential life processes, including nutrient cycling, stress resistance, and immunity.
The scientific community is increasingly recognizing the importance of considering soil and plant microbiomes for human health. However, the question of whether unifying beneficial or harmful functions exist across these diverse ecosystems is more complex. Current data and results remain largely indirect and hypothetical. In this regard, researchers propose integrating coevolutionary concepts, where human, soil, plant, and gut microbiomes can influence each other's evolutionary trajectories over time. This approach provides a better understanding of the exchange and interaction between soil and human gut microbiomes (Ma et al., 2025). This coevolution of microbiomes is a clear manifestation of the principles of “One Health.” This concept is based on the recognition that human health is inextricably linked to the health of soil, plants, and animals, and that microbial play a central role in this network.
The “One Health” concept emphasizes the inextricable link between human health and wellbeing and the health of other ecosystem components, such as soil, plants, and animals. Accumulating evidence indicates that microorganisms play a crucial role in the “One Health” concept by connecting these components. The health of ecosystems largely depends on the contribution of microbial communities (Berg et al., 2020). Numerous studies now demonstrate that microbial communities associated with plants, animals, and humans function as a “second genome” (Berendsen et al., 2012), an “extended genotype” (Carthey et al., 2018), or an “eco-holobiont” (Singh et al., 2020). These communities thus determine the viability and productivity of almost all organisms on Earth. Additionally, research increasingly suggests that microbial communities of different organisms are interconnected and form a closed loop (Adair et al., 2018).
Regarding the microbiome, bacterial strains partition within and between domains, forming distinct microbial communities through mechanisms described in ecology as “strain dispersal” and “ecological filtering.” Thus, the microbiomes of humans, animals, and plants comprise the “One Health Microbiome” (Wallenborn and Vonaesch, 2022), and such research should adhere to a “One Health” approach.
Taking a “One Health” approach to comprehensively study the microbiome and how it is transmitted in the environment (including the human gut) will facilitate the transfer of common concepts between different fields and accelerate translational efforts to develop targeted microbiota-based interventions. This approach, and its predictive capabilities, will enable the rational design of microbiome interventions to benefit human, animal, and environmental health (Muhummed et al., 2025).
Consequently, this review establishes a theoretical framework for advancing our understanding of how microbiome transplantation influences ecosystem resilience across both agricultural and clinical domains. By synthesizing evidence on microbiota transplantation in various environments, this work elucidates a conceptual bridge grounded in universal symbiotic principles and the restoration of ecological homeostasis, thereby highlighting critical interdisciplinary research trajectories.
Statements
Author contributions
VR: Conceptualization, Funding acquisition, Project administration, Writing – original draft, Writing – review & editing. IV: Conceptualization, Writing – original draft, Writing – review & editing. KI: Conceptualization, Writing – original draft, Writing – review & editing. EB: Investigation, Writing – original draft. VK: Investigation, Writing – original draft. AR: Data curation, Formal analysis, Writing – review & editing. DK: Investigation, Visualization, Writing – original draft. MM: Investigation, Visualization, Writing – original draft. AZ: Investigation, Validation, Writing – review & editing.
Funding
The author(s) declared that financial support was received for this work and/or its publication. The research was conducted with the support of the grant from the Russian Science Foundation, project number 25-76-10071.
Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
AdairK. L.WilsonM.BostA.DouglasA. E. (2018). Microbial community assembly in wild populations of the fruit fly Drosophila melanogaster. ISME J.12, 959–972. doi: 10.1038/s41396-017-0020-x
2
AghiliF.JansaJ.KhoshgoftarmaneshA. H.AfyuniM.SchulinR.FrossardE.et al. (2014). Wheat plants invest more in mycorrhizae and receive more benefits from them under adverse than favorable soil conditions. Agric,. Ecosyst. Environ. Appl. Soil Ecol.84, 93–111. doi: 10.1016/j.apsoil.2014.06.013
3
AlbornozF. E.ProberS. M.RyanM. H.StandishR. J. (2022). Ecological interactions among microbial functional guilds in the plant–soil system and implications for ecosystem function. Plant Soil476, 1–13. doi: 10.1007/s11104-022-05479-1
4
AlbrightM.LoucaS.WinklerD. E.FeeserK. L.HaigS.WhitesonK.et al. (2021). Solutions in microbiome engineering: prioritizing barriers to organism establishment. ISME J.16:331. doi: 10.1038/s41396-021-01088-5
5
AllegrettiJ. R.MullishB. H.KellyC.et al. (2019). The evolution of the use of faecal microbiota transplantation and emerging therapeutic indications. Lancet394, 420–431. doi: 10.1016/S0140-6736(19)31266-8
6
AnandG.GoelV.DubeyS.SharmaS. (2021). Tailoring the rhizospheric microbiome of Vigna radiata by adaptation to salt stress. Plant Growth Regul.93, 79–88. doi: 10.1007/s10725-020-00667-4
7
AqueelM. A.AnjumS. I.UllahA.et al. (2023). Microbiota transplantation for cotton leaf curl disease suppression—core microbiome and transcriptome dynamics. Commun. Biol. 8, 380. doi: 10.1038/s41522-023-00470-9
8
ArnaultG.MonyC.VandenkoornhuyseP. (2023). Plant microbiota dysbiosis and the Anna Karenina Principle. Trends Plant Sci.28, 18–30. doi: 10.1016/j.tplants.2022.08.012
9
ArshadM. A.HassanF. U.RehmanM. S.HuwsS. A.ChengY.DinA.U. (2021). Gut microbiome colonization and development in neonatal ruminants: strategies, prospects, and opportunities. Anim. Nutr.7, 883–895. doi: 10.1016/j.aninu.2021.03.004
10
BelancheA.de la FuenteG.NewboldC. J. (2015). Effect of progressive inoculation of fauna free sheep with holotrich protozoa and total fauna on rumen fermentation, microbial diversity and methane emissions. FEMS Microbiol. Ecol.91:fiu026. doi: 10.1093/femsec/fiu026
11
BenetkovaP.van DiggelenR.HanelL.VicentiniF.MoradiR.WeijtersM.et al. (2022). Soil fauna development during heathland restoration from arable land: role of soil modification and material transplant. Ecol. Eng.176:106531. doi: 10.1016/j.ecoleng.2021.106531
12
BerendsenR. L.PieterseC. M. J.BakkerP. A. H. M. (2012). The rhizosphere microbiome and plant health. Trends Plant Sci.17, 478–486. doi: 10.1016/j.tplants.2012.04.001
13
BergG.RybakovaD.FischerD.CernavaT.VergèsM.-C. C.CharlesT.et al. (2020). Microbiome definition re-visited: old concepts and new challenges. Microbiome8, 1–22. doi: 10.1186/s40168-020-00875-0
14
BiazzoM.DeiddaG. (2022). Fecal microbiota transplantation as new therapeutic avenue for human diseases. J. Clin. Med.11:4119. doi: 10.3390/jcm11144119
15
BieganskaE. A.KosińskiP.WolskiM. (2025). Possible applications of fecal microbiota transplantation in the pediatric population: a systematic review. Biomedicines13:1393. doi: 10.3390/biomedicines13061393
16
BindiyaE. S.TinaK. J.RaghulS. S.BhatS. G. (2015). Characterization of deep sea fish gut bacteria with antagonistic potential, from Centroscyllium fabricii deep sea shark. Probiotics Antimicrob. Proteins7, 157–163. doi: 10.1007/s12602-015-9190-x
17
BirdS. H.HegartyR. S.WoodgateR. (2008). Persistence of defaunation effects on digestion and methane production in ewes. Aust. J. Exp. Agric.48, 152–155. doi: 10.1071/EA07298
18
BlytonM. D. J.SooR.M.WhissonD.et al. (2019). Faecal inoculations alter the gastrointestinal microbiome and allow dietary expansion in a wild specialist herbivore, the koala. Anim. Microbiome1:6. doi: 10.1186/s42523-019-0008-0
19
BolsegaS.BleichA.BasicM. (2021). Synthetic microbiomes on the rise – application in deciphering the role of microbes in host health and disease. Nutrients13:4173. doi: 10.3390/nu13114173
20
BornbuschS. L.HarrisR. L.GrebeN. M.RocheK.Dimac-StohlK.DreaC. M. (2021). Antibiotics and fecal transfaunation differentially affect microbiota recovery, associations, and antibiotic resistance in lemur guts. Anim Microbiome3:65. doi: 10.1186/s42523-021-00126-z
21
BrownV. S.EricksonT. E.MerrittD. J.MadsenM. D.HobbsR. J.RitchieA. L. (2021). A global review of seed enhancement technology use to inform improved applications in restoration. Sci. Total Environ.798:149096. doi: 10.1016/j.scitotenv.2021.149096
22
CammarotaG.IaniroG.TilgH.et al. (2017). European consensus conference on faecal microbiota transplantation in clinical practice. Gut66, 569–580. doi: 10.1136/gutjnl-2016-313017
23
CartheyA. J. R.GillingsM. R.BlumsteinD. T. (2018). The extended genotype: microbially mediated olfactory communication. Trends Ecol. Evol.33, 885–894. doi: 10.1016/j.tree.2018.08.010
24
ChaitmanJ.JergensA.GaschenF.Garcia-MazcorroJ. F.MarksS.Marroquin-CardonaA.et al. (2016). Commentary on key aspects of fecal microbiota transplantation in small animal practice. Vet. Med.7, 71–74. doi: 10.2147/VMRR.S105238
25
ChandravanshiS.KumariR.ChakrabortyD.et al. (2025). Advances in microbiome engineering for enhancing fish health and disease resistance in aquaculture. Int. J. Adv. Biochem. Res.9, 447–453. doi: 10.33545/26174693.2025.v9.i12f.6531
26
CharitosI. A.ScaccoS.CotoiaA.CastellanetaF.CastellanaG.PasqualottoF.et al. (2025). Intestinal microbiota dysbiosis role and bacterial translocation as a factor for septic risk. Int. J. Mol. Sci.26:2028. doi: 10.3390/ijms26052028
27
ChaudharyA.ChaudharyP.UpadhyayA.KumarA.SinghA. (2022). Effect of gypsum on plant growth promoting rhizobacteria. Environ. Ecol.39, 1248–1256. https://environmentandecology.com/wp-content/uploads/2024/09/MS36-1.pdf
28
ChvojkaJ. (2025). Biorestorer: synthetic succession for soil restoration in arid and degraded regions. EarthArXiv [Preprint]. Available online at: EarthArXiv Preprint (Accessed February 19, 2026). doi: 10.31223/X5P44H
29
CobanO.de DeynG. B.van der PloegM. (2022). Soil microbiota as game changers in restoration of degraded lands. Science375:abe0725. doi: 10.1126/science.abe0725
30
ContosP.WoodJ. L.MurphyN. P.GibbH. (2021). Rewilding with invertebrates and microbes to restore ecosystems: present trends and future directions. Ecol. Evol.11, 7187–7200. doi: 10.1002/ece3.7597
31
CusterG.BrescianiL.Dini AndreoteF. (2023). Toward an integrative framework for microbial community coalescence. Trends Microbiol.32:241. doi: 10.1016/j.tim.2023.09.001
32
CymbalM.ChatterjeeA.BaggottB. (2025). Fecal microbiota transplantation: current evidence and future directions. Cleve. Clin. J. Med.92, 421–428. doi: 10.3949/ccjm.92a.24107
33
DadzieF. A.MolesA. T.EricksonT. E.SlavichE.Muñoz RojasM. (2022). Native bacteria and cyanobacteria can influence seedling emergence and growth of native plants used in dryland restoration. J. Appl. Ecol.59, 2983–2992. doi: 10.1111/1365-2664.14293
34
DaiW.LengH.LiJ.et al. (2024). The role of host traits and geography in shaping the gut microbiome of insectivorous bats. mSphere9, e00087–e00024. doi: 10.1128/msphere.00087-24
35
DaloisoV.MinacoriR.RefoloP.SacchiniD.CraxìL.GasbarriniA.et al. (2015). Ethical aspects of fecal microbiota transplantation (FMT). Eur. Rev. Med. Pharmacol. Sci.19, 3173–3180. Available online at: https://pubmed.ncbi.nlm.nih.gov/26400519/
36
de BashanL. E.HernandezJ. P.BashanY. (2012). Microbial amelioration of crop salinity stress. J. Exp. Bot.63, 3415–3428. doi: 10.1093/jxb/ers033
37
De SciscioM.BryantR. V.Haylock JacobsS.et al. (2025). Faecal microbiota transplant in Parkinson's disease: pilot study to establish safety & tolerability. NPJ Parkinsons Dis.11:203. doi: 10.1038/s41531-025-01061-5
38
DePetersE. J.GeorgeL.W. (2014). Rumen transfaunation. Immunol. Lett.162, 69–76. doi: 10.1016/j.imlet.2014.05.009
39
DiambraL. (2025). Network-based community analysis of microbial composition: insights into dysbiosis and assembly. Comput. Biol. Med.198:111190. doi: 10.1016/j.compbiomed.2025.111190
40
DiwanA. D.HarkeS. N.GopalkrishnaP. A. N. (2022). Aquaculture industry prospective from gut microbiome of fish and shellfish: an overview. J. Anim. Physiol. Anim. Nutr.106, 441–469. doi: 10.1111/jpn.13619
41
Domínguez CastilloC.Alatorre CruzJ. M.Castañeda AntonioD.MuniveJ. A.GuoX.López OlguínJ. F.et al. (2021). Potential seed germination enhancing plant growth promoting rhizobacteria for restoration of Pinus chiapensis ecosystems. J. For. Res.32, 2143–2153. doi: 10.1007/s11676-020-01250-3
42
DouJ.BennettM. R. (2018). Synthetic biology and the gut microbiome. Biotechnol. J.13:1700159. doi: 10.1002/biot.201700159
43
DuhanP.GuptaB.AhmedM. M. M.BansalP. (2025). Gut microbiome engineering with probiotics: current trends and future directions. Discov. Appl. Sci.7:7622. doi: 10.1007/s42452-025-07622-w
44
DuPontH. L.SuescunJ.JiangZ. D.BrownE. L.EssigmannH. T.AlexanderA. S.et al. (2023). Fecal microbiota transplantation in Parkinson's disease – a randomized repeat dose, placebo controlled clinical pilot study. Front. Neurol.14:1104759. doi: 10.3389/fneur.2023.1104759
45
El SonM. A. M.ElbahnaswyS.KhormiM. A.AborasainA. M.AbdelhaffezH. H.ZahranE. (2025). Harnessing the fish gut microbiome and immune system to enhance disease resistance in aquaculture. Fish Shellfish Immunol.163:110394. doi: 10.1016/j.fsi.2025.110394
46
ErenA. M.BanfieldJ. F. (2024). Modern microbiology: embracing complexity through integration across scales. Cell187:5151. doi: 10.1016/j.cell.2024.08.028
47
FanL.ChenJ.ZhangQ.et al. (2025). Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo controlled trial. Microbiome13:133. doi: 10.1186/s40168-025-02118-6
48
GaoC.HuangQ.YangX.et al. (2025). Diet and environment drive the convergence of gut microbiome in wild released giant pandas and forest musk deer. iScience28:112837. doi: 10.1016/j.isci.2025.112837
49
GerritsG. M.WaeninkR.AradottirA. L.BuissonE.DutoitT.FerreiraM. C.et al. (2023). Synthesis on the effectiveness of soil translocation for plant community restoration. J. Appl. Ecol.60, 714–724. doi: 10.1111/1365-2664.14364
50
GogartenJ. F.DaviesT. J.BenjaminoJ.GogartenJ. P.GrafJ.MielkeA.et al. (2018). Factors influencing bacterial microbiome composition in a wild non human primate community in Taï National Park, Côte d'Ivoire. ISME J.12, 2559–2574. doi: 10.1038/s41396-018-0166-1
51
GornishE.ArnoldH.FehmiJ. (2019). Review of seed pelletizing strategies for arid land restoration. Restor. Ecol.27, 1206–1211. doi: 10.1111/rec.13045
52
GuoH.FuX.HeJ.WangR.YanM.WangJ.et al. (2023). Gut bacterial consortium enriched in a biofloc system protects shrimp against Vibrio parahaemolyticus infection. Microbiome11:230. doi: 10.1186/s40168-023-01663-2
53
HanS. I. (2020). Indigenous microbiome transplantation for the environment friendly bioremediation. Microbiol. Soc. Korea56, 1–9.
54
HanZ.SunJ.JiangB.et al. (2024). Fecal microbiota transplantation accelerates restoration of florfenicol disturbed intestinal microbiota in a fish model. Commun. Biol.7:1006. doi: 10.1038/s42003-024-06727-z
55
HartmannM.FreyB.MayerJ.MäderP.WidmerF. (2015). Distinct soil microbial diversity under long term organic and conventional farming. ISME J.9, 1177–1194. doi: 10.1038/ismej.2014.210
56
HniniM.RabehK.OubohssaineM. (2025). Understanding plant-microorganism interactions: the key roles of soil, rhizosphere, and direct and indirect mechanisms. AIMS Microbiol.11:1035. doi: 10.3934/microbiol.2025046
57
HuC.LiJ.LiuM.LamP. K. S.ChenL. (2022a). Young fecal transplantation modulates the visual toxicity of perfluorobutanesulfonate in aged zebrafish recipients. Aquat. Toxicol.251:106295. doi: 10.1016/j.aquatox.2022.106295
58
HuC.SunB.LiuM.YuJ.ZhouX.ChenL. (2022b). Fecal transplantation from young zebrafish donors efficiently ameliorates the lipid metabolism disorder of aged recipients exposed to perfluorobutanesulfonate. Sci. Total Environ.823:153758. doi: 10.1016/j.scitotenv.2022.153758
59
HuJ.ZengJ.ShiY.SongS. (2022). Are microbes and metabolites influencing the parental consumption of nestlings' feces in gray-backed shrikes?. Curr. Zool.68, 667–678. doi: 10.1093/cz/zoac005
60
JouanyJ.P.UshidaK. (1999). The role of protozoa in feed digestion-review. Asian-Australas. J. Anim. Sci.12, 113–128. doi: 10.5713/ajas.1999.113
61
KambleN. S. (2024). Review on applied applications of microbiome on human lives. Bacteria3, 141–159. doi: 10.3390/bacteria3030010
62
KanikaN. H.LiaqatN.ChenH.KeJ.LuG.WangJ.et al. (2025). Fish gut microbiome and its application in aquaculture and biological conservation. Front. Microbiol.15:1521048. doi: 10.3389/fmicb.2024.1521048
63
KaurS.EgidiE.QiuZ. Macdonald C,.A Verma J,.P TrivediP. (2022). Synthetic community improves crop performance and alters rhizosphere microbial communities. J. Sustain. Agric. Environ.1, 118–131. doi: 10.1002/sae2.12017
64
KellyC.R.KhorutsA.StaleyC.et al. (2016). Effect of fecal microbiota transplantation on recurrence in multiply recurrent Clostridioides difficile infection: a randomized trial. Ann. Intern. Med.165, 609–616. doi: 10.7326/M16-0271
65
KhannaS.Vázquez BaezaY.GonzálezA.et al. (2017). Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease. Microbiome5:55. doi: 10.1186/s40168-017-0269-3
66
KhorutsA.StaleyC.SadowskyM.J. (2021). Faecal microbiota transplantation for Clostridioides difficile: mechanisms and pharmacology. Nat. Rev. Gastroenterol. Hepatol.18, 67–80. doi: 10.1038/s41575-020-0350-4
67
KimK. O.GluckM. (2019). Fecal microbiota transplantation: an update on clinical practice. Clin. Endosc.52:137. doi: 10.5946/ce.2019.009
68
KogutM. H.LeeA.SantinE. (2020). Microbiome and pathogen interaction with the immune system. Poult. Sci.99, 1906–1913. doi: 10.1016/j.psj.2019.12.011
69
KootteR. S.LevinE.SalojärviJ.et al. (2017). Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab.26, 611–619. doi: 10.1016/j.cmet.2017.09.008
70
KowalM. (2025). Microbiome and wellbeing: a meta-analysis. NPJ Biofilms Microbiomes11:201. doi: 10.1038/s41522-025-00829-0
71
KoziolL. Schultz P,.A House G,.L Bauer J,.T Middleton E,.L Bever J,.D. (2018). The plant microbiome and native plant restoration: the example of native mycorrhizal fungi. Bioscience68, 996–1006. doi: 10.1093/biosci/biy125
72
KumarP.SinhaR.ShuklaP. (2022). Artificial intelligence and synthetic biology approaches for human gut microbiome. Crit. Rev. Food Sci. Nutr.62, 2103–2121. doi: 10.1080/10408398.2020.1850415
73
KumariS.SharmaA.ChaudharyP.KhatiP. (2020). Management of plant vigor and soil health using two agriusable nanocompounds and plant growth promotory rhizobacteria in fenugreek. 3 Biotech10:461. doi: 10.1007/s13205-020-02448-2
74
LeeE. D.AurandE. R.FriedmanD.C. E. B. R. C.Microbiome Engineering Roadmapping Working Group, (2020). Engineering microbiomes—looking ahead. ACS Synth. Biol.9:3181. doi: 10.1021/acssynbio.0c00558
75
LennonJ. T.FrostS. D. W.NguyenN. K.PeraltaA. L.PlaceA. R.TresederK. K. (2023). Microbiology and climate change: a transdisciplinary imperative. mBio14, e03335–e03322. doi: 10.1128/mbio.03335-22
76
Lev SagieA.Goldman WohlD.CohenY.et al. (2019). Vaginal microbiome transplantation in women with intractable bacterial vaginosis. Nat. Med.25, 1500–1504. doi: 10.1038/s41591-019-0600-6
77
LiS. S.ZhuA.BenesV.et al. (2016). Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science352, 586–589. doi: 10.1126/science.aad8852
78
LiW.EdwardsA.RiehleC.et al. (2019). Transcriptomics analysis of host liver and meta-transcriptome analysis of rumen epimural microbial community in young calves treated with artificial dosing of rumen content from adult donor cow. Sci. Rep.9:790. doi: 10.1038/s41598-018-37033-4
79
LinL.XuS.CaiM.LiS.ChenY.ChenL.et al. (2024). Effects of fecal microbiota transfer on blood pressure in animal models: a systematic review and meta analysis. PLoS ONE19:e0300869. doi: 10.1371/journal.pone.0300869
80
LinnehanB. K.KoderaS. M.AllardS. M.BrodieE. C.AllabandC.KnightR.et al. (2024). Evaluation of the safety and efficacy of fecal microbiota transplantations in bottlenose dolphins (Tursiops truncatus) using metagenomic sequencing. J. Appl. Microbiol.135:lxae026. doi: 10.1093/jambio/lxae026
81
LuckyC.W. (2025). Microbiome therapeutics for Clostridioides difficile infection. Infect. Dis. Clin. North Am.39, 663–683. doi: 10.1016/j.idc.2025.07.007
82
LuoH.ZhouC.ZhouL.et al. (2024). The effectiveness of vaginal microbiota transplantation for vaginal dysbiosis and bacterial vaginosis: a scoping review. Arch. Gynecol. Obstet.310, 643–653. doi: 10.1007/s00404-024-07611-1
83
MaH.CornadóD.RaaijmakersJ. M. (2025). The soil plant human gut microbiome axis into perspective. Nat. Commun.16:7748. doi: 10.1038/s41467-025-62989-z
84
MaY.LiuJ.RhodesC.NieY.ZhangF. (2017). Ethical issues in fecal microbiota transplantation in practice. Am. J. Bioeth.17, 34–45. doi: 10.1080/15265161.2017.1299240
85
MandalR. S. K.JoshiV.BalamuruganB.GautamD.ChethanG.E.LekshmanA. (2017). Rumen transfaunation an effective method for treating simple indigestion in ruminants. North East Vet.17, 31–33. doi: 10.7748/ns.31.25.17.s20
86
ManzaneraM. (2025). From microbial consortia to ecosystem resilience: the integrative roles of holobionts in stress Biology. Biology14:1203. doi: 10.3390/biology14091203
87
MassotF.BernardN. Alvarez L,.M. M. et al. (2022). Microbial associations for bioremediation. what does “microbial consortia” mean?Appl. Microbiol. Biotechnol.106, 2283–2297. doi: 10.1007/s00253-022-11864-8
88
MendesR.GarbevaP.RaaijmakersJ. M. (2013). The rhizosphere microbiome: significance of plant beneficial, plant pathogenic, and human pathogenic microorganisms. FEMS Microbiol. Rev.37, 634–663. doi: 10.1111/1574-6976.12028
89
MengY.SunJ.ZhangG. (2024). Vaginal microbiota transplantation is a truly opulent and promising edge: fully grasp its potential. Front. Cell. Infect. Microbiol.14:1280636. doi: 10.3389/fcimb.2024.1280636
90
MitterB.BraderG.PfaffenbichlerN.SessitschA. (2019). Next generation microbiome applications for crop production—limitations and the need of knowledge based solutions. Curr. Opin. Microbiol.49, 59–65. doi: 10.1016/j.mib.2019.10.006
91
MohrJ.JHarrisonP.AStanhopeJ.BreedM.F. (2022). Is the genomics ‘cart' before the restoration ecology ‘horse'? Insights from qualitative interviews and trends from the literature. Philos. Trans. R. Soc. B377:20210381. doi: 10.1098/rstb.2021.0381
92
MoralesC.BallesteroL.del RíoP.Barbero HerranzR.OlavarrietaL.Gómez ArtíguezL.et al. (2024). Should the faecal microbiota composition be determined to certify a faecal donor?Diagnostics14:2635. doi: 10.3390/diagnostics14232635
93
MorellaN. M.Cheng Hsuan WengF.JoubertaP. M.MetcalfC. J. E.LindowS.KoskellaB. (2020). Successive passaging of a plant associated microbiome reveals robust habitat and host genotype dependent selection. Proc. Natl. Acad. Sci. USA117, 1148–1159. doi: 10.1073/pnas.1908600116
94
MuhummedA. M.LankerK. C.YersinS.et al. (2025). One health, one microbiome. Microbiome13:216. doi: 10.1186/s40168-025-02231-6
95
MullenK. R.YasudaK.DiversT. J.WeeseJ. S. (2018). Equine faecal microbiota transplant: current knowledge, proposed guidelines and future directions. Equine Vet. Educ.30, 151–160. doi: 10.1111/eve.12559
96
MuellerU. G.SachsJ. L. (2015). Engineering microbiomes to improve plant and animal health. Trends Microbiol.23, 606–617. doi: 10.1016/j.tim.2015.07.009
97
Muñoz RojasM. (2018). Soil quality indicators: critical tools in ecosystem restoration. Curr. Opin. Environ. Sci. Health5, 47–52. doi: 10.1016/j.coesh.2018.04.007
98
NazirA.HussainF. H. N.RazaA. (2024). Advancing microbiota therapeutics: the role of synthetic biology in engineering microbial communities for precision medicine. Front. Bioeng. Biotechnol.12:1511149. doi: 10.3389/fbioe.2024.1511149
99
NiederwerderM. C. (2018). Fecal microbiota transplantation as a tool to treat and reduce susceptibility to disease in animals. Vet. Immunol. Immunopathol.206, 65–72. doi: 10.1016/j.vetimm.2018.11.002
100
NiederwerderM. C.ConstanceL. A.RowlandR. R. R.AbbasW.FernandoS.CPotterM.L.et al. (2018). Fecal microbiota transplantation is associated with reduced morbidity and mortality in porcine circovirus associated disease. Front. Microbiol.9:1631. doi: 10.3389/fmicb.2018.01631
101
NitisoravutR.RegmiR. (2017). Plant microbial fuel cells: a promising biosystems engineering. Renew. Sustain. Energy Rev.76, 81–89. doi: 10.1016/j.rser.2017.03.064
102
OoijevaarR. E.TerveerE. M.VerspagetH. W.et al. (2019). Clinical application and potential of fecal microbiota transplantation. Annu. Rev. Med.70, 335–351. doi: 10.1146/annurev-med-111717-122956
103
Panke-BuisseK.PooleA. C.GoodrichJ. K.LeyR. E.Kao-KniffinJ. (2015). Selection on soil microbiomes reveals reproducible impacts on plant function. ISME J.9, 980–989. doi: 10.1038/ismej.2014.196
104
ParamsothyS.KammM.AKaakoushN. O.et al. (2017). Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo controlled trial. Lancet389, 1218–1228. doi: 10.1016/S0140-6736(17)30182-4
105
PereiraG. Q.GomesL. A.SantosI. S.AlfieriA. F.WeeseJ. S.CostaM. C. (2018). Fecal microbiota transplantation in puppies with canine parvovirus infection. J. Vet. Intern. Med.32, 707–711. doi: 10.1111/jvim.15072
106
Pérez CastroS.ClelandE.EWagnerR.et al. (2019). Soil microbial responses to drought and exotic plants shift carbon metabolism. ISME J.13, 1776–1787. doi: 10.1038/s41396-019-0389-9
107
PillaG.McFarlandA. G.HryckowianA. J. (2025). The emerging view on the roles of butyrate in Clostridioides difficile pathogenesis. Infect. Immun.93, e00047–e00025. doi: 10.1128/iai.00047-25
108
PorterN. T.LarsbrinkJ. (2022). Investigation and alteration of organic acid synthesis pathways in the mammalian gut symbiont Bacteroides thetaiotaomicron. Microbiol. Spectr.10, e02312–e02321. doi: 10.1128/spectrum.02312-21
109
RagerK. D.GeorgeL. W.HouseJ. K.DePetersE. J. (2004). Evaluation of rumen transfaunation after surgical correction of left sided displacement of the abomasum in cows. J. Am. Vet. Med. Assoc.225, 915–920. doi: 10.2460/javma.2004.225.915
110
RawatV. S.KaurJ.BhagwatS.PanditM. A.RawatC. D. (2022). Deploying microbes as drivers and indicators in ecological restoration. Restor. Ecol.31:e13688. doi: 10.1111/rec.13688
111
RayP.LakshmananV.LabbéJ. L.CravenK. D. (2020). Microbe to microbiome: a paradigm shift in the application of microorganisms for sustainable agriculture. Front. Microbiol.11:622926. doi: 10.3389/fmicb.2020.622926
112
RaymoG.AliA.AhmedR. O.SalemM. (2024). Early life fecal transplantation from high muscle yield rainbow trout to low muscle yield recipients accelerates somatic growth through respiratory and mitochondrial efficiency modulation. Microorganisms12:261. doi: 10.3390/microorganisms12020261
113
RidauraV. K.FaithJ. J.ReyF. E.et al. (2013). Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science341:1241214. doi: 10.1126/science.1241214
114
RománJ.RChiltonA.CantónY.Muñoz RojasM. (2020). Assessing the viability of cyanobacteria pellets for application in arid land restoration. J. Environ. Manage.270:110795. doi: 10.1016/j.jenvman.2020.110795
115
SequeirosC.GarcesM. E.VallejoM.MarguetE. R.OliveraN. L. (2015). Potential aquaculture probiont Lactococcus lactis TW34 produces nisin Z and inhibits the fish pathogen Lactococcus garvieae. Arch. Microbiol.197, 449–458. doi: 10.1007/s00203-014-1076-x
116
ShenY. (2025). Gut microbiota dysbiosis: pathogenesis, diseases, prevention, and therapy. MedComm.6:e70168. doi: 10.1002/mco2.70168
117
SilvaA. M.AraújoV. L.CardosoE. J. (2023). Revisiting the past to understand the present and future of soil health in Brazil. Front. Soil Sci.3:1172436. doi: 10.3389/fsoil.2023.1172436
118
SinghB. K.LiuH.TrivediP. (2020). Eco holobiont: a new concept to identify drivers of host associated microorganisms. Environ. Microbiol.22, 564–567. doi: 10.1111/1462-2920.14900
119
SinghB. K.YanZ. Z.WhittakerM.VargasR.AbdelfattahA. (2023). Soil microbiomes must be explicitly included in One Health policy. Nat. Microbiol.8, 1367–1372. doi: 10.1038/s41564-023-01386-y
120
SmillieC. S.SaukJ.GeversD.et al. (2018). Strain tracking reveals the determinants of bacterial engraftment in the human gut following fecal microbiota transplantation. Cell Host Microbe23, 229–240. doi: 10.1016/j.chom.2018.01.003
121
SolansM.PellizaY.ITadeyM. (2022). Inoculation with native Actinobacteria may improve desert plant growth and survival with potential use for restoration practices. Microb. Ecol.83, 380–392. doi: 10.1007/s00248-021-01753-4
122
SongL. (2023). Toward understanding microbial ecology to restore a degraded ecosystem. Int. J. Environ. Res. Public Health20:4647. doi: 10.3390/ijerph20054647
123
SonnenburgJ. L.BäckhedF. (2016). Diet microbiota interactions as moderators of human metabolism. Nature535, 56–64. doi: 10.1038/nature18846
124
SothS.HamptonJ.GAlizadehH.WakelinS. A.Mendoza MendozaA. (2025). Microbiomes in action: multifaceted benefits and challenges across academic disciplines. Front. Microbiol.16:1550749. doi: 10.3389/fmicb.2025.1550749
125
StockE.StandishR. J.Muñoz RojasM.BellR. W.EricksonT. E. (2020). Field deployed extruded seed pellets show promise for perennial grass establishment in arid zone mine rehabilitation. Front. Ecol. Evol.8:576125. doi: 10.3389/fevo.2020.576125
126
SuezJ.ZmoraN.Zilberman SchapiraG.et al. (2018). Post antibiotic gut mucosal microbiome reconstitution is impaired by probiotics and improved by autologous FMT. Cell174, 1406–1423. doi: 10.1016/j.cell.2018.08.047
127
SunB.WangF.JiangY.LiY.DongZ.LiZ.et al. (2014). A long term field experiment of soil transplantation demonstrating the role of contemporary geographic separation in shaping soil microbial community structure. Ecol. Evol.4, 1073–1087. doi: 10.1002/ece3.1006
128
TakizawaS.ShinkaiT.SaitoK.et al. (2023). Effect of rumen microbiota transfaunation on the growth, rumen fermentation, and microbial community of early separated Japanese black cattle. Anim. Sci. J.94:e13876. doi: 10.1111/asj.13876
129
TaurY.CoyteK.SchluterJ.et al. (2018). Reconstitution of the gut microbiota of antibiotic treated patients by autologous fecal microbiota transplant. Sci. Transl. Med.10:eaap9489. doi: 10.1126/scitranslmed.aap9489
130
TayyabM.ZhaoY.ZhangY. (2025). Microbiome engineering to enhance disease resistance in aquaculture: current strategies and future directions. Front. Microbiol.16:1625265. doi: 10.3389/fmicb.2025.1625265
131
ThukralM.AllenA.EPetrasD. (2023). Progress and challenges in exploring aquatic microbial communities using non-targeted metabolomics. ISME J.17, 2147–2159. doi: 10.1038/s41396-023-01532-8
132
TuniyaziM.ZhangN. (2023). Possible therapeutic mechanisms and future perspectives of vaginal microbiota transplantation. Microorganisms11:1427. doi: 10.3390/microorganisms11061427
133
Van NoodE.VriezeA.NieuwdorpM.et al. (2013). Duodenal infusion of donor feces for recurrent Clostridioides difficile. N. Engl. J. Med.368, 407–415. doi: 10.1056/NEJMoa1205037
134
VidevallE.BenschH. M.EngelbrechtA.CloeteS.CornwallisC. K. (2023). Coprophagy rapidly matures juvenile gut microbiota in a precocial bird. Evol. Lett.7, 240–251. doi: 10.1093/evlett/qrad021
135
WallenbornJ. T.VonaeschP. (2022). Intestinal microbiota research from a global perspective. Gastroenterol. Rep.10:goac010. doi: 10.1093/gastro/goac010
136
WangX.ShangY.XingY.ChenY.WuX.ZhangH. (2025). Captive environments reshape the compositions of carbohydrate active enzymes and virulence factors in wolf gut microbiome. BMC Microbiol.25:142. doi: 10.1186/s12866-025-03863-2
137
WangY.ZhangS.BorodyT. J.ZhangF. (2022). Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases. Chin. Med. J.135:1927–1939. doi: 10.1097/CM9.0000000000002339
138
WilsonB. C.VatanenT.CutfieldW. S.et al. (2019). The super donor phenomenon in fecal microbiota transplantation. Front. Cell. Infect. Microbiol.9:2. doi: 10.3389/fcimb.2019.00002
139
WubsE. R. J.van der PuttenW. H.BoschM.BezemerT. M. (2016). Soil inoculation steers restoration of terrestrial ecosystems. Nat. Plants2:16107. doi: 10.1038/nplants.2016.107
140
WubsE. R. J.van der PuttenW. H.MortimerS. R.KorthalsG. W.DuytsH.WagenaarR.et al. (2019). Single introductions of soil biota and plants generate long term legacies in soil and plant community assembly. Ecol. Lett.22, 1145–1151. doi: 10.1111/ele.13271
141
XuW.XuN.ZhangQ.et al. (2023). Association between diet and the gut microbiome of young captive red crowned cranes (Grus japonensis). BMC Vet. Res.19:80. doi: 10.1186/s12917-023-03636-x
142
YadegarA.Bar YosephH.MonaghanT.PakpourS.SeverinoA.KuijperE.J.et al. (2024). Fecal microbiota transplantation: current challenges and future landscapes. Clin. Microbiol. Rev.37, e00060–e00022. doi: 10.1128/cmr.00060-22
143
YockeyL. J.HussainF. A.BergeratA.et al. (2022). Screening and characterization of vaginal fluid donations for vaginal microbiota transplantation. Sci. Rep.12:17948. doi: 10.1038/s41598-022-22873-y
144
YooJ.Y.GroerM.DutraS.V. O.SarkarA.McSkimmingD.I. (2020). Gut microbiota and immune system interactions. Microorganisms8:1587. doi: 10.3390/microorganisms8101587
145
YoungV.DohaiB.HalderH.et al. (2026). Effector-host interactome map links type III secretion systems in healthy gut microbiomes to immune modulation. Nat. Microbiol.11, 442–460. doi: 10.1038/s41564-025-02241-y
146
YukgehnaishK.KumarP.SivachandranP.MarimuthuK.ArshadA.ParayB. A.et al. (2020). Gut microbiota metagenomics in aquaculture: factors influencing gut microbiome and its physiological role in fish. Rev. Aquac.12, 1903–1927. doi: 10.1111/raq.12416
147
ZhangJ.CookJ.NearingJ.TZhangJ.RaudonisR.GlickB.R.et al. (2021). Harnessing the plant microbiome to promote the growth of agricultural crops. Microbiol. Res.245:126690. doi: 10.1016/j.micres.2020.126690
148
ZhangM.LiY.LiY.ChengC.ChaiS.YangY.et al. (2025). Effects of rumen fluid transplantation on the fecal flora of yaks. Front Anim Sci5:1507838. doi: 10.3389/fanim.2024.1507838
149
ZhangT.LiM.ShiT.YanY.NiyazbekovaZ.WangX.et al. (2022). Transmission of the gut microbiome in cohousing goats and pigs. Front. Microbiol.13:948617. doi: 10.3389/fmicb.2022.948617
150
ZhaoY.LiE.QiuY.MaX.XiaoD.LiZ. (2025). Mechanisms underlying the effects of rumen microbiota transplantation on the growth and development of ruminants. Fermentation11:674. doi: 10.3390/fermentation11120674
151
ZhengD.LiwinskiT.ElinavE. (2020). Interaction between microbiota and immunity in health and disease. Cell Res.30, 492–506. doi: 10.1038/s41422-020-0332-7
152
ZhongH. J.ZengH. L.CaiY. L.ZhuangY. P.LiouY. L.WuQ.et al. (2021). Washed microbiota transplantation lowers blood pressure in patients with hypertension. Front. Cell. Infect. Microbiol.11:679624. doi: 10.3389/fcimb.2021.679624
153
ZhouM.PengY.JChenY.et al. (2018). Assessment of microbiome changes after rumen transfaunation: implications on improving feed efficiency in beef cattle. Microbiome6:62. doi: 10.1186/s40168-018-0447-y
154
ZhuL.ZhangY.CuiX.ZhuY.DaiQ.ChenH.et al. (2021). Host bias in diet-source microbiome transmission in wild cohabitating herbivores: new knowledge for the evolution of herbivory and plant defense. Microbiol. Spectr.9, e00756–e00721. doi: 10.1128/Spectrum.00756-21
Summary
Keywords
aquaculture microbiome, engineered microbial consortia, fecal microbiota transplantation, FMT, synthetic microbiome
Citation
Ryazanov V, Vershinina I, Inchagova K, Bukareva E, Kolpakov V, Ruchay A, Kosyan D, Marinchev M and Zdorov A (2026) Fecal microbiota and microbial community transplantation: a review of current research. Front. Microbiol. 17:1814047. doi: 10.3389/fmicb.2026.1814047
Received
20 February 2026
Revised
15 May 2026
Accepted
20 May 2026
Published
05 June 2026
Volume
17 - 2026
Edited by
Fadwa Jroundi, University of Granada, Spain
Reviewed by
Emma Rocke, University of Cape Town, South Africa
Debabrata Chowdhury, Iowa State University, Ames, IA, United States
Updates
Copyright
© 2026 Ryazanov, Vershinina, Inchagova, Bukareva, Kolpakov, Ruchay, Kosyan, Marinchev and Zdorov.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Irina Vershinina, gavrish.irina.ogu@gmail.com
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.